Stockreport
3 Generic Drug Stocks to Watch Amid Challenging Market Prospects [Yahoo! Finance]
Last amgen inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations: investors.amgen.com
Apart from intense regulatory pressure on drug quality and manufacturing, the generic drugs industry also faces cut-throat competition stemming from the presence of numerous drugmakers. The only respite available to such drugmakers is a first-to-file or first-to-market opportunity wherein they enjoy exclusivity for a limited period. Companies like Teva Pharmaceuticals TEVA, Dr. Reddy's Laboratories RDY and Viatris VTRS are poised to beat the macroeconomic headwinds on the back of continued demand for their existing products, new product launches and cost optimization policies. Industry Description The Medical - Generic Drugs industry comprises companies that develop and market chemically/biologically identical versions of a brand-name drug once patents, providing exclusivity to branded drugs, expire. These drugs can be divided into generic and biosimilar categories based on their composition. The generic segment is controlled by a few large drugmakers and generic units of large
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | AMGN | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
AMGN alerts
AMGN alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMGN alerts
High impacting Amgen Inc. news events
Weekly update
A roundup of the hottest topics
AMGN
NEWS
NEWS
- Amgen surges over confidence in early obesity drug results [Yahoo! Finance Canada][Yahoo! Finance Canada]
- Amgen surges over confidence in early obesity drug results [Yahoo! Finance][Yahoo! Finance]
- Amgen Inc. (NASDAQ: AMGN) was upgraded by analysts at Barclays PLC from an "underweight" rating to an "equal weight" rating. They now have a $300.00 price target on the stock, up previously from $230.00.[MarketBeat]
- Amgen Inc. (NASDAQ: AMGN) was upgraded by analysts at William Blair from a "market perform" rating to an "outperform" rating.[MarketBeat]
- Novo Slides as Amgen Update Fuels Obesity Drug Competition Fears [BNN Bloomberg (Canada)][BNN Bloomberg]
- More
AMGN
SEC Filings
SEC Filings
- 5/3/24 - Form 10-Q
- 5/2/24 - Form 4
- 5/2/24 - Form 4
- AMGN's page on the SEC website
- More